# A Phase II Trial of MB-6 Plus FOLFOX4 for Metastatic Colorectal Cancer (FDA IND 103675)

> **NCT01047475** · PHASE2 · COMPLETED · sponsor: **Microbio Co Ltd** · enrollment: 72 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** MB-6
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01047475
- **Lead sponsor:** Microbio Co Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-04
- **Final completion:** 2011-12
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2015-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01047475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01047475, "A Phase II Trial of MB-6 Plus FOLFOX4 for Metastatic Colorectal Cancer (FDA IND 103675)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01047475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*